Sequencing continues to have the potential to rework medical microbiology and even public well being by enabling the simultaneous, hypothesis-free identification of a number of disease-causing organisms (together with micro organism, viruses, fungi and parasites). A number of approaches for any such testing exist – from sampling of microbes in sources of an infection to newer cell-free approaches from physique fluids. Regardless of its large promise, sequencing has not seen the routine uptake many predicted resulting from quite a lot of technical, scientific and broader structural causes.
Whereas implementation in routine follow stays in early levels, the potential impression on healthcare supply and affected person outcomes warrants severe consideration from forward-looking healthcare leaders.
Be part of us for a dynamic moderated dialogue between two widely known consultants within the discipline of microbiology, Charles Chiu, MD PhD, and Brad Perkins, MD, as they talk about the way forward for sequencing in medical microbiology.
Dialogue Highlights:
- Sequencing’s transformative potential in diagnostics.
- Actual-world affected person impression and success tales.
- Assessing the place we’re within the adoption cycle.
- Advances in varied sorts of methodologies, infrastructure, and approaches.
- Addressing unmet wants in infectious illness diagnostics and healthcare supply.
- Constructing the medical proof base to drive broader adoption.
- Overcoming limitations by innovation, collaboration, and guideline improvement.
- Envisioning the long run.
